
---
title: '如何优化狂犬病疫苗的接种方案'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://picsum.photos/400/300?random=4477'
author: 科学网
comments: false
date: Thu, 29 Jul 2021 12:54:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=4477'
---

<div>   
<p style="margin-left: 0;text-indent: 67px;line-height: 200%"><span style="font-family: URWPalladioL-Bold;line-height: 200%;font-size: 29px">如何优化狂犬病疫苗的接种方案</span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"> </span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">细胞培养狂犬病疫苗</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">CCV</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">最早于</span>20世纪80年代获得批准，是预防人类狂犬病的重要手段。由</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">WHO</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">推荐的第一个</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">暴露后预防</span>(PEP)</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">疫苗接种方案</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">需要</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">在长达三个月的时间内</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">进行一系列</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">肌肉注射。</span></span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-size: 24px;"><strong><span style="font-family: KaiTi; line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF;"><span style="font-family: KaiTi;">为了在不影响安全性的情况下降低</span>PEP的成本，缩短所需的时间，</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">WHO</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">鼓励对</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">接种方案</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">进行</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">进一步</span></strong><strong><span style="font-family: KaiTi; line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF;"><span style="font-family: KaiTi;">的研究，包括开发成本更低的</span>CCV生产方法和通过</span></strong><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF;"><span style="font-family: KaiTi;">皮内</span>(ID)</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">途径</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">接种</span></strong><strong><span style="font-family: KaiTi; line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF;"><span style="font-family: KaiTi;">体积更小的</span>CCV。</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">在过去四十年中进行的</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">众多临床试验一直在</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">研究用于</span></strong><strong><span style="font-family: KaiTi; line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF;">PEP</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">和</span></strong><strong><span style="text-decoration: underline; line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">暴露前预防</span></strong><strong><span style="text-decoration: underline; line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">（</span></strong><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF;">PrEP</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">）的</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">缩短</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">的</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">疫苗接种</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">替代</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">方案。</span></strong></span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">大量临床试验提供了足够的数据，支持减少剂量，</span><span style="font-family:KaiTi">缩短</span>PEP所需的时间，</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">并</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">批准</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">了在</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP和PrEP</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">时采用</span></span><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">皮内</span></span></span><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（</span></span></span><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">ID</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">)</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">注射</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">进行接种</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">。然而，自</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">CCV</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">开发以来公布的过多数据可能会让公共卫生官员无法接受，他们希望审查并决定在其</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">所在</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">区域采用最合适的</span>PEP和PrEP方案。</span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">CCV</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">在预防死亡和改变预防人类狂犬病的公共卫生策略中的作用</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">再怎么评估也</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">不能</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">算</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">夸大。如果最初</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">将</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">CCV</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">用于</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">人</span>PEP的漫长和昂贵的疫苗接种方案保持不变，各国政府很可能就不会有及时</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">替换</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">神经组织疫苗</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"> </span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（</span><span style="font-family:KaiTi"> </span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">nervous tissue vaccines</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">NTV</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的动力。显然，国家卫生机构希望建立新的或更新目前的人类狂犬病预防</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">方案</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，需要考虑和评估广泛的数据。然而，使用不同疫苗、</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">不同接种</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径和时间表的过多已公布信息可能使直接比较数据变得困难和复杂。目前，在比较</span></span><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">IM</span></span><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（肌肉内注射</span></span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">方案和</span></span><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">ID</span></span><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（皮内注射</span></span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">方案的数据时，还没有精确的科学方法来证实在各个可能的免疫学方面的绝对等效性。</span></span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">在</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">比较来自狂犬病</span>IM和ID</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">疫苗接种试验的已发表的临床数据时，有三个标准可以作为确定的等效基准。这三个标准包括</span>:</span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（</span><span style="font-family:KaiTi">1）</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">免疫原性</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">immunogenicity</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，即提供疫苗接种后产生</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RVNA</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（狂犬病毒中和抗体）</span></span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的证据</span>;</span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（</span><span style="font-family:KaiTi">2）</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">有效性</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">effificacy</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，即证明一种新方案可以保护曾</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">暴露于</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">实验室确诊的</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">患</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">狂犬病动物的患者</span>;</span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">(3)</span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">记忆</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">反应</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">anamnestic response</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，即确保以前接种过疫苗的患者</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">在</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">接受加强</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">针</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">疫苗时，患者的免疫系统立即开始产生</span>RVNA。</span></p><p style="margin-left: 0;text-indent: 55px;line-height: 200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">（</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">１</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"> </span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">免疫原性</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">（</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF">immunogenicity</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span></strong></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP和PrEP后产生的</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RVNA</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">是疫苗接种后成功免疫反应的重要组成部分。事实上</span>,</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">对</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">暴露于疑似或</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">确诊患有</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">狂犬病的动物</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">患者</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，建议的</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP程序</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">包括在首针疫苗接种的同时或在此后</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">7天内</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">注射</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">狂犬病免疫球蛋白</span>(RIG</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">)</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RIG</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">含有</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RVNA</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">。</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">以</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RIG</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">形式出现的</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">被动免疫</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">passive immunity</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，通过使伤口部位能够尽快获得</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RVNA</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，消除暴露于创伤期间可能</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">沾染</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的狂犬病毒，有助于降低疾病进展的风险。在接种第一剂疫苗超过</span>7天</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">后</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，患者自身的免疫系统就会开始产生</span>RVNAs(</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">主动免疫</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">)。</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">一般来说，在接种第一剂疫苗后，患者的免疫系统产生可检测到的</span>RVNA需要7 </span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">－</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF">14天</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">。</span></span></strong></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="line-height: 200%; color: #333333; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">基于上述原因，免疫原性是新</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="line-height: 200%; color: #333333; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">方案概念验证的第一步。</span><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; color: #333333; letter-spacing: 0px; font-size: 21px; background: #FFFFFF;"><span style="font-family:KaiTi">在第</span>14天或之前检测到</span><strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; color: #333333; letter-spacing: 0px; font-size: 21px; background: #FFFFFF;">RVNA</span></strong><span style="text-decoration: underline; font-family: KaiTi; line-height: 200%; color: #333333; letter-spacing: 0px; font-size: 21px; background: #FFFFFF;"><span style="font-family:KaiTi">的存在被认为是正在考虑的</span>PEP方案产生强大的免疫反应的证据。</span><span style="color: #0070C0; font-size: 24px;"><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">还</span></strong><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">没有一个</span></strong><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">确定的抗体</span></strong><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">滴度值被证明</span></strong><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">是</span></strong><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">对人类有保护作用</span></strong><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">的阀值</span></strong><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">。显然，进行一项临床试验，让人类受到狂犬病毒的挑战，以确定确切的保护性抗体水平</span></strong><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">阀值</span></strong><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">，将是不道德的</span></strong><strong><span style="color: #0070C0; line-height: 200%; letter-spacing: 0px; background: #FFFFFF; font-family: KaiTi;">，实际上不可能进行。</span></strong></span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"> <span style="font-family:KaiTi">然而，</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">开始接种疫苗后第</span>14天的血清学滴度为0.5 IU / mL</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">通常</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">被认为是</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">有</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">足够免疫</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">力的</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">证明。</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">在检测</span>RVNA值时，重要的是要</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">采</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">用一种实际测量</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">中和抗体</span></span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">而不是</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">结合抗体</span></span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的方法。</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">快速荧光</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">灶</span></span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">抑制试验</span>(RFFIT</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">)和</span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">荧光抗体中和试验</span>(FAVN</span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">)均适用于</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">检测</span></span><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">中和抗体</span></span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，而</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">ELISA</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">检测的是</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">结合抗体</span></span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（与</span></span><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">中和抗体</span></span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">只是有一定相关性）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">。</span></span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">大多数评估新方案或替代方案有效性的临床试验还包括评估临床试验中不同时间点</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RVNA</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">水平的方案，以跟踪免疫反应的动力学。目前被列为</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">WHO</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">资格预</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">论证</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的四种</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">CCV</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">均进行</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">过</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">临床试验，并公布了数据，证明它们在</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">IM</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（肌肉内注射）或</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">ID</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（皮内注射）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"> </span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">后确实产生了强大的免疫应答，并确认</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RVNA</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">在开始接种疫苗后的第</span>14天存在。</span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="color: #0070C0;"><span style="line-height: 200%; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">建议因职业或爱好原因而使其暴露于狂犬病风险增加的人进行</span><strong><span style="font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 21px; background: #FFFFFF;">PrEP</span></strong><span style="line-height: 200%; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">，疫苗接种应在暴露发生前进行。</span></span><span style="line-height: 200%; color: #333333; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">尽管确认一种新的</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PrEP</span></strong><span style="line-height: 200%; color: #333333; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">方案可导致</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RVNA</span></strong><span style="line-height: 200%; color: #333333; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">产生很重要，但</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PrEP</span></strong><span style="line-height: 200%; color: #333333; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">的主要目标不是对最近的暴露做出尽快产生</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RVNA</span></strong><span style="line-height: 200%; color: #333333; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">的反应。相反，</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PrEP的</span></strong><strong><span style="line-height: 200%; color: #FF0000; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">主要</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">目的是消除使用</span>RIG的需要，并启动免疫系统，以便在未来暴露于狂犬病的情况下，引发对加强疫苗的快速免疫反应。</span></strong></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">因此，一些检查新的</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PrEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">方案的研究没有包括第</span>14天的血液样本，但在临床试验的时间轴晚些时候提取了血液样本，例如</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">在</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">第</span>35天。在检查新的</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PrEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">方案时，证明疫苗或方案引起</span></span><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">免疫反应</span></span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">是确认接种过疫苗的人在注射加强剂或一系列疫苗时也有快速</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">记忆</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">反应的第一步。在</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PrEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">临床试验中，在开始接种疫苗后的第</span>14至35天抽血，并进行</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">检测</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">以确认</span>RVNA的存在，可以提供所需的证据，以确认所考虑的方案是</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">能保证</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">免疫原性的。</span></span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">在许多研究中，通过</span>IM和ID途径对PrEP的免疫反应进行了比较，随着新数据的获得，WHO更新了对PrEP的建议。</span><span style="color: #0070C0;"><span style="font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 21px; background: #FFFFFF;">目前，</span><strong><span style="font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 21px; background: #FFFFFF;">WHO</span></strong><span style="line-height: 200%; letter-spacing: 0px; font-size: 21px; background: #FFFFFF; font-family: KaiTi;">对</span><strong><span style="font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 21px; background: #FFFFFF;">PrEP</span></strong><span style="font-family: KaiTi; line-height: 200%; letter-spacing: 0px; font-size: 21px; background: #FFFFFF;"><span style="font-family: KaiTi;">的建议是间隔7天共接种2针（</span>IM<span style="font-family: KaiTi;">）或2次（</span>ID<span style="font-family: KaiTi;">）</span> <span style="font-family: KaiTi;">。</span></span></span></p><p style="margin-left: 0;text-indent: 55px;line-height: 200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">（</span><span style="font-family:KaiTi">2）有效性（Effificacy）</span></span></strong></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"> <span style="font-family:KaiTi">由于</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">显而易见</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的原因，证明新提出的</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">方案的</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">有效性</span></span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">是极为重要的。只有在免疫原性得到证实后，才能进行临床试验以证明其有效性。在进行临床试验以证明有效性时，重要的是能够从</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">暴露</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的动物中收集诊断样本</span>(即脑组织)，并将它们提交给可靠的狂犬病诊断实验室，以确认动物</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">确实</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">患了狂犬病。</span></span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">第一次证明</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">HDCV</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">（人二倍体细胞疫苗</span></span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">有效性的现场试验是在</span>1975年至1976年期间在</span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">伊朗</span></span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">进行的，涉及被确诊为</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">患</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">狂犬病的狼和狗咬伤的</span>45名患者。44</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">名</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">患者同时接受抗狂犬病血清治疗。一个暴露于气溶胶狂犬病的病人没有给予抗狂犬病血清。皮下注射六剂</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">HDCV</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，所有患者都存活下来，证明</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">HDCV</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">是有效的，可以预防</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">暴露于</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">狂犬病患者的疾病。</span></span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">通过</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">ID</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">接种</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">CCV</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">也需要证明其安全性和有效性。第一个调查</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">ID</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span> </span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">有效性的研究是在泰国进行的，包括</span>58</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">名</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">患者。这项研究包括</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">曾轻微暴露于患</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">狂犬病动物的患者。研究人员检查了接种疫苗后的</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">RVNA</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">反应</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">和</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">患者的生存率，</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">将</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">接受三种</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">ID</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">方案中的一种</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的患者，与</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">接受</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">WHO</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">推荐的</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">IM</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">五</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">针</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">方案的</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">患者进行比较</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">。所有患者在第</span>14天和第35天(抽取血液进行检测的最后一天)</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">都是</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">存活</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">，</span></span><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">中和抗体</span></span></span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">滴度</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">都</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">超过</span>0.5 IU/mL。</span></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">上述</span>Phanuphak及其同事进行的</span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">ID</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">研究在</span>Chutivongse等人在泰国进行的第二项研究中得到了证实。第二项研究招募了100名被确诊为</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">患</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">狂犬病动物严重咬伤的患者，所有患者在接种疫苗后随访一年。所有患者在注射最后一剂疫苗一年后都被确认存活。最初的</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">这</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">两项有效性研究提供了根据上述时间表给予</span>ID </span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP与IM </span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP同样有效的证据，并</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">提供了样板，可用于</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">设计</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">类似的</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">临床试验</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">以</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">评估新的</span>PEP方案</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">有效性。进一步的临床研究证实，其他经</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">过</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">WHO</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">资格预</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">论证</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">的狂犬病疫苗对</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">IM</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">和</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">ID</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">途径</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">都是安全有效的</span></span></p><p style="margin-left: 0;text-indent: 55px;line-height: 200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">（</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">３</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">）记忆反应（</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF">Anamnestic Response</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 24px;background: #FFFFFF"><span style="font-family:KaiTi">）</span></span></strong></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">显然，</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">和</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PrEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">都是保护有感染狂犬病风险的人的有效策略。然而，</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">和</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PrEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">后达到预防疾病的方法是不同的。证明</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF">PEP</span></strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">后出现</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">记忆</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">反应不是首要目标，然而，这</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">却</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">是狂犬病暴露风险较高的人接受预防</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">性</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">接种的两个基本原因之一。</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">进行预防</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">性</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">接种是为了确保接种过疫苗的人在未来暴露于狂犬病的情况下，能够对加强</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">针</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">疫苗产生快速的</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">记忆</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">反应。</span></span></strong></p><p style="margin-left: 0;text-indent: 47px;line-height: 200%"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">有几项研究评估并确认了通过</span>IM和ID途径接受PrEP的患者(包括接受初始PrEP系列后10 - 24年)在</span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">加强针</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">后出现</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">记忆</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">反应的证据。重要的是，在给予加强</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">针</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">或疫苗剂量前提取血液样本，以便量化加强</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">针</span></span><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">前的基线滴度。</span></span><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">加强</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">针</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">注射后，应在第</span>7 - 10天第二次抽取血液样本，以确定滴度已出现上升，从而确认已发生</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">记忆</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:KaiTi">反应。</span></span></strong></p><p style="text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 24px">参考文献：</span></strong></p><p style="margin-left: 0px; text-indent: 43px; line-height: 200%;"><span style="font-family: URWPalladioL-Roma;line-height: 200%;font-size: 19px">Briggs, D.J.; Moore, S.M. </span><span style="font-family: URWPalladioL-Roma;line-height: 200%;font-size: 19px">The Route of Administration of Rabies Vaccines: Comparing the Data. </span><em><span style="font-family: URWPalladioL-Ital;line-height: 200%;font-size: 19px">Viruses </span></em><span style="font-family: URWPalladioL-Bold;line-height: 200%;font-size: 19px">2021</span><span style="font-family: URWPalladioL-Roma;line-height: 200%;font-size: 19px">, </span><em><span style="font-family: URWPalladioL-Ital;line-height: 200%;font-size: 19px">13</span></em><span style="font-family: URWPalladioL-Roma;line-height: 200%;font-size: 19px">, 1252. </span></p><p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310204/" target="_blank"><span style="text-decoration:underline;"><span style="font-family: Calibri;color: #800080;font-size: 19px">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310204/</span></span></a><span style="text-indent: 43px; font-family: URWPalladioL-Roma; line-height: 200%; font-size: 19px;"> </span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="http://blog.sciencenet.cn/blog-347754-1297500.html" target="_blank" style="font-size:13px; color:#850f0f">http://blog.sciencenet.cn/blog-347754-1297500.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1297116.html" target="_black">不应当因病毒在暴发流行中发生变异而恐慌</a><br>                    <!--大赛结束-->
                                        
  
</div>
            